Feb 8 |
Sensus Healthcare GAAP EPS of $0.26 beats by $0.12, revenue of $12.6M beats by $0.54M
|
Feb 8 |
Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results
|
Feb 8 |
Sensus Healthcare announces U.S. patent for SRT-100 Vision System
|
Feb 8 |
Sensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) Capabilities
|
Feb 7 |
Sensus Healthcare Q4 2023 Earnings Preview
|
Feb 6 |
Sensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory Requirements
|
Feb 1 |
Earnings Preview: Sensus Healthcare, Inc. (SRTS) Q4 Earnings Expected to Decline
|
Feb 1 |
Sensus Healthcare Announces Retirement of Director Samuel O’Rear
|
Feb 1 |
Inogen (INGN) Surges 12.3%: Is This an Indication of Further Gains?
|
Jan 30 |
Sensus Healthcare to Host Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call on Thursday, February 8, 2024
|